CompletedNot Applicable

Observational and Analytical Study on the Diagnostic Criteria for Sarcopenia in Institutionalized Older Adults and Those Living in the Community

Spain415 participantsStarted 2022-01-01

Plain-language summary

Sarcopenia is one of the main problems in the elderly population. However, its diagnostic criteria have not yet been studied in two specific populations, namely institutionalized older adults in nursing homes vs community-dwelling older adults. So this will be the objective of the study. An observational study is being conducted to analyze how these diagnostic criteria relate to each other and to find possible associations.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * older adults who have been institutionalized for at least one year * older adults who are institutionalized with clinical suspicion of sarcopenia according to the Sarc-F questionnaire and muscle strength criteria * older adults residing in the community of Extrema Exclusion Criteria: * present cognitive impairment (score \<24 Mini-Mental State Examination) * primary, serious, or chronic diseases that could explain the decrease in muscle strength and the other diagnostic variables of the participants * diseases or physical disorders that hinder the assessment of the participants; -use of drugs that may affect muscle strength and mass \[35\].

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Hand grip strenght

Timeframe: Once at the baseline

Trial details

NCT IDNCT07080554

SponsorUniversity of Extremadura

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-01

View on ClinicalTrials.gov More Sarcopenia in Elderly trials